Dr Robert Day

Université de Sherbrooke

Dr Robert Day
A new treatment strategy for prostate cancer

Dr Robert Day at the Université de Sherbrooke provided the first proof of concept that blocking a protein called PACE4 stops prostate cancer growth in mice. Anti-PACE4 therapy triggered prostate cancer cells to die and shrank tumours by 60%. A new collaboration is now advancing clinical testing and commercialization.

Reference: Oncotarget, February 2015